BIOMAT Database Logo BIOMAT Database Logo

Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry. 1999

O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Division of Human Genetics, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.

The South African population harbors genes that are derived from varying degrees of admixture between indigenous groups and immigrants from Europe and the East. This study represents the first direct mutation-based attempt to determine the impact of admixture from other gene pools on the familial hypercholesterolemia (FH) phenotype in the recently founded Coloured population of South Africa, a people of mixed ancestry. A cohort of 236 apparently unrelated patients with clinical features of FH was screened for a common mutation causing familial defective apolipoprotein B-100 (FDB) and seven low-density lipoprotein receptor (LDLR) gene defects known to be relatively common in South Africans with FH. Six founder-type 'South African mutations' were responsible for FH in approximately 20% of the study population, while only 1 patient tested positive for the familial defective apolipoprotein B-100 mutation R3500Q. The detection of multiple founder-type LDLR gene mutations originating from European, Indian and Jewish populations provides direct genetic evidence that Caucasoid admixture contributes significantly to the apparently high prevalence of FH in South African patients of mixed ancestry. This study contributes to our knowledge of the biological history of this unique population and illustrates the potential consequences of recent admixture in populations with different disease risks.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D013019 South Africa A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960. Republic of South Africa,Union of South Africa
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D018703 Founder Effect A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup's GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive. Effect, Founder,Effects, Founder,Founder Effects

Related Publications

O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.
December 1993, Human genetics,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects.
December 1994, Atherosclerosis,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients.
July 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Multiple mutations underlying familial hypercholesterolemia in the South African population.
August 1989, Human genetics,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Familial hypercholesterolemia in South African Afrikaners. PvuII and StuI DNA polymorphisms in the LDL-receptor gene consistent with a predominating founder gene effect.
September 1987, Human genetics,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia.
January 1997, Human mutation,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.
January 1994, Arteriosclerosis and thrombosis : a journal of vascular biology,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian origin.
August 1993, Biochimica et biophysica acta,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia.
June 1995, Human genetics,
O Loubser, and A D Marais, and M J Kotze, and N Godenir, and R Thiart, and C L Scholtz, and J N de Villiers, and R Hillermann, and J C Firth, and H F Weich, and F Maritz, and S Jones, and D R van der Westhuyzen
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia.
February 1996, Clinical genetics,
Copied contents to your clipboard!